CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Taigen Biopharmaceuticals Holdings Ltd Company Snapshot
Taigen Biopharmaceuticals Holdings Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Taigen Biopharmaceuticals Holdings Ltd with three other companies in this sector in Taiwan: Foresee Pharmaceuticals Co Ltd (2018 sales of 26.04 million Taiwanese Dollars [US$857,105.12 ] ), Pharmadax Inc (35.88 million Taiwanese Dollars [US$1.18 million] of which 91% was Sales), and Twi Biotechnology Inc (25.84 million Taiwanese Dollars [US$850,554.04 ] of which 100% was Sales Income).

Sales Analysis. Sales fell dramatically in 2018: Taigen Biopharmaceuticals Holdings Ltd reported sales of 29.62 million Taiwanese Dollars (US$975.02 thousand) for the year ending December of 2018. This represents a sharp decrease of 94.6% versus 2017, when the company's sales were 553.21 million Taiwanese Dollars. Contributing to the drop in overall sales was the 95.1% decline in Medical Development, from 550.66 million Taiwanese Dollars to 27.04 million Taiwanese Dollars. . However, these declines were partially offset by the increase in sales of Medical Consultance (up 1.2% to 2.58 million Taiwanese Dollars) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Taigen Biopharmaceuticals Holdings Ltd
  Stock Performance Chart for Taigen Biopharmaceuticals Holdings Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 22.25
(Figures in Taiwanese Dollars)
1 Week 8.0%   13 Weeks 28.6%  
4 Weeks 36.5%   52 Weeks 33.6%  
 
Taigen Biopharmaceuticals Holdings Ltd Key Data:
  Ticker: 4157 Country: Taiwan
  Exchanges: TAI Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 29,618,000
(Year Ending Jan 2019).
Employees: N/A
  Currency: Taiwanese Dollars Market Cap: 15,948,755,500
  Fiscal Yr Ends: December Shares Outstanding: 716,798,000
  Share Type: Ordinary Closely Held Shares: 439,096,000
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.